Health

Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering

August 28, 2025 19:36 ET  | Source: Picard Medical, Inc. TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical,…

5 months ago

Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors

August 28, 2025 19:30 ET  | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle…

5 months ago

Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated August 28, 2025 18:12 ET  | Source: Rakovina Therapeutics Inc…

5 months ago

International Observers Raise Concerns Over Judicial Irregularities in Senegal; Rights Advocates Stress Importance for Governance and Investment

Khadim Ba, a Non-Executive Director at DerMond Oil & Gas LOS ANGELES, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Independent legal…

5 months ago

Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock

August 27, 2025 20:53 ET  | Source: Cognition Therapeutics, Inc. - The offering was made to two new fundamental institutional…

5 months ago

Tilray Brands Successfully Regains Compliance with Nasdaqs Minimum Bid Price Requirement

NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY;…

5 months ago

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French…

5 months ago

Idorsia successfully completes convertible bonds restructuring

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 27, 2025Idorsia Ltd (SIX: IDIA) settled the repurchase…

5 months ago

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich,…

5 months ago

Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress

- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX…

5 months ago